Why the SK Capital Acquisition of Swixx Biopharma Might Be a Value Trap
Private equity is shifting towards Swiss drug distribution investments.
Private equity is shifting towards Swiss drug distribution investments.
TPG faces a significant loss from its cosmetics investment.
Utah’s investment signifies a new era in private equity.